Intensive glucose control in patients with type 2 diabetes - 15-year follow-up.
Open accessAbstract
BACKGROUND: We previously reported that a median of 5.6 years of intensive as compared with standard glucose lowering in 1791 military veterans with type 2 diabetes resulted in a risk of major cardiovascular events that was significantly lower (by 17%) after a total of 10 years of combined intervention and observational follow-up. We now report the full 15-year follow-up. METHODS: We observationally followed enrolled participants (complete cohort) after the conclusion of the original clinical trial by using central databases to identify cardiovascular events, hospitalizations, and deaths. Participants were asked whether they would be willing to provide additional data by means of surveys and chart reviews (survey cohort). The prespecified primary outcome was a composite of major cardiovascular events, including nonfatal myocardial infarction, nonfatal stroke, new or worsening congestive heart failure, amputation for ischemic gangrene, and death from cardiovascular causes. Death from any cause was a prespecified secondary outcome. RESULTS: There were 1655 participants in the complete cohort and 1391 in the survey cohort. During the trial (which originally enrolled 1791 participants), the separation of the glycated hemoglobin curves between the intensive-therapy group (892 participants) and the standard-therapy group (899 participants) averaged 1.5 percentage points, and this difference declined to 0.2 to 0.3 percentage points by 3 years after the trial ended. Over a period of 15 years of follow-up (active treatment plus post-trial observation), the risks of major cardiovascular events or death were not lower in the intensive-therapy group than in the standard-therapy group (hazard ratio for primary outcome, 0.91; 95% confidence interval [CI], 0.78 to 1.06; P = 0.23; hazard ratio for death, 1.02; 95% CI, 0.88 to 1.18). The risk of major cardiovascular disease outcomes was reduced, however, during an extended interval of separation of the glycated hemoglobin curves (hazard ratio, 0.83; 95% CI, 0.70 to 0.99), but this benefit did not continue after equalization of the glycated hemoglobin levels (hazard ratio, 1.26; 95% CI, 0.90 to 1.75). CONCLUSIONS: Participants with type 2 diabetes who had been randomly assigned to intensive glucose control for 5.6 years had a lower risk of cardiovascular events than those who received standard therapy only during the prolonged period in which the glycated hemoglobin curves were separated. There was no evidence of a legacy effect or a mortality benefit with intensive glucose control. (Funded by the VA Cooperative Studies Program; VADT ClinicalTrials.gov number, NCT00032487.).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315 · see citing works
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · see citing works
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · see citing works
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · see citing works
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · see citing works
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · see citing works
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900 · see citing works
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138 · see citing works
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · see citing works
Self-citationGupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,019 · see citing works
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N. R., & Golden, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00007 · Cited by 1,657 · see citing works
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030405011 · Cited by 1,482 · see citing works
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189 · see citing works
Self-citationStratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019 · see citing works
Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00006 · Cited by 974 · see citing works
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712 · see citing works
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Hayward, R. A., Reaven, P. D., Wiitala, W. L., Bahn, G. D., Reda, D. J., Ge, L., McCarren, M., Duckworth, W. C., & Emanuele, N. V. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414266 · Cited by 668 · see citing works
Self-citationFollow-up of blood-pressure lowering and glucose control in type 2 diabetes
Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407963 · Cited by 626 · see citing works
Kiyota, Y., Schneeweiß, S., Glynn, R. J., Cannuscio, C. C., Avorn, J., & Solomon, D. H. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.02.013 · Cited by 533 · see citing works
The Evaluation of Two Measures of Quality of Life in Patients With Type I and Type II Diabetes
Jacobson, A. M., de Groot, M., & SAMSON, J. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.4.267 · Cited by 510 · see citing works
The DCCT Research Group (1988) · Diabetes Care · doi:10.2337/diacare.11.9.725 · Cited by 509 · see citing works
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A. (2010) · Trials · doi:10.1186/1745-6215-11-85 · Cited by 504 · see citing works
Self-citationAdler, A., Boyko, E. J., Ahroni, J. H., Stensel, V. L., Forsberg, R. C., & Smith, D. G. (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1162 · Cited by 363 · see citing works
Chalmers, J., & Cooper, M. E. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807625 · Cited by 263 · see citing works
Petersen, L. A., Wright, S. M., Normand, S. T., & Daley, J. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.10198.x · Cited by 233 · see citing works
Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes
The ACCORD Study Group (2016) · Diabetes Care · doi:10.2337/dc15-2283 · Cited by 193 · see citing works
Reaven, P. D., MORITZ, T. E., Schwenke, D. C., Anderson, R. J., Criqui, M. H., Detrano, R., Emanuele, N., Kayshap, M., Marks, J. B., Mudaliar, S. R. D., et al. (2009) · Diabetes · doi:10.2337/db09-0618 · Cited by 182 · see citing works
Self-citationHayward, R. A., Hofer, T. P., & Vijan, S. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-7-200610030-00010 · Cited by 164 · see citing works
Self-citationDesign of the cooperative study on glycemic control and complications in diabetes mellitus type 2
Abraira, C., Duckworth, W. C., McCarren, M., Emanuele, N., Arca, D., Reda, D. J., & Henderson, W. G. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00277-5 · Cited by 161 · see citing works
Self-citationLegacy Effects from DCCT and UKPDS: What They Mean and Implications for Future Diabetes Trials
Murray, P. T., Chune, G., & Raghavan, V. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0128-1 · Cited by 78 · see citing works
Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes
Mazzone, T. (2010) · Circulation · doi:10.1161/circulationaha.109.913350 · Cited by 75 · see citing works
Kirkman, M. S., McCarren, M., Shah, J. H., Duckworth, W. C., & Abraira, C. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.06.013 · Cited by 60 · see citing works
Self-citationHyperglycemia and Vascular Metabolic Memory: Truth or Fiction?
Bianchi, C., Miccoli, R., & Prato, S. D. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0371-2 · Cited by 47 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 762 · see citing works
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O. C., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 408 · see citing works
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage
Diener, H., & Hankey, G. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.072 · Cited by 376 · see citing works
Edgar, L., Akbar, N., Braithwaite, A. T., Krausgruber, T., Gallart-Ayala, H., Bailey, J., Corbin, A., Khoyratty, T. E., Chai, J. T., Alkhalil, M., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.046464 · Cited by 352 · see citing works
Cardiovascular disease in diabetes, beyond glucose
Eckel, R. H., Bornfeldt, K., & Goldberg, I. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.001 · Cited by 224 · see citing works
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management
Zotin, M. C. Z., Sveikata, L., Viswanathan, A., & Yilmaz, P. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000913 · Cited by 203 · see citing works
Zhang, Y., Cui, Y., Shen, M., Zhang, J., Liu, B., Dai, M., Chen, L., Han, D., Fan, Y., Zeng, Y., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108227 · Cited by 184 · see citing works
Goldberg, R. B., Orchard, T. J., Crandall, J. P., Boyko, E. J., Budoff, M. J., Dabelea, D., Gadde, K. M., Knowler, W. C., Lee, C. G., Nathan, D. M., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056756 · Cited by 184 · see citing works
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
Rodriguez-Gutierrez, R., Gonzalez-Gonzalez, J. G., Zuñiga-Hernandez, J. A., & McCoy, R. G. (2019) · BMJ · doi:10.1136/bmj.l5887 · Cited by 152 · see citing works
Primary prevention of ischaemic heart disease: populations, individuals, and health professionals
Gupta, R., & Wood, D. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31893-8 · Cited by 154 · see citing works
Cardiovascular outcomes in type 1 and type 2 diabetes
Rosengren, A., & Dikaiou, P. (2023) · Diabetologia · doi:10.1007/s00125-022-05857-5 · Cited by 156 · see citing works
Diagnosis and Treatment of Type 2 Diabetes in Adults
Kalyani, R. R., Neumiller, J. J., Maruthur, N. M., & Wexler, D. J. (2025) · JAMA · doi:10.1001/jama.2025.5956 · Cited by 145 · see citing works
Xu, C., Jiang, D., Ge, Y., Huang, L., Xiao, Y., Ren, X., Liu, X., Zhang, Q., & Wang, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.134109 · Cited by 145 · see citing works
Glycaemic management in diabetes: old and new approaches
Ceriello, A., Prattichizzo, F., Phillip, M., Hirsch, I. B., Mathieu, C., & Battelino, T. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00245-x · Cited by 146 · see citing works
Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88
Lind, M., Imberg, H., Coleman, R. L., Nerman, O., & Holman, R. R. (2021) · Diabetes Care · doi:10.2337/dc20-2439 · Cited by 128 · see citing works
Fuchigami, A., Shigiyama, F., Kitazawa, T., Okada, Y., Ichijo, T., Higa, M., Hiyoshi, T., Inoue, I., Iso, K., Yoshii, H., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0977-z · Cited by 124 · see citing works
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Goodarzi, M. O., & Rotter, J. I. (2020) · Circulation Research · doi:10.1161/circresaha.119.316065 · Cited by 117 · see citing works
Diabetes and Cardiovascular Disease: an Update
Almourani, R., Chinnakotla, B., Patel, R., Kurukulasuriya, L. R., & Sowers, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1239-x · Cited by 114 · see citing works
Edgar, L., Akbar, N., Braithwaite, A. T., Krausgruber, T., Gallart‐Ayala, H., Bailey, J. D., Corbin, A., Khoyratty, T. E., Chai, J. T., Alkhalil, M., et al. (2021) · Informationszentrum Lebenswissenschaften (ZB MED) · doi:10.1161/circulationaha.120.04646 · Cited by 113 · see citing works
Rosen, C. J., & Ingelfinger, J. R. (2026) · New England Journal of Medicine · doi:10.1056/nejmra2500106 · Cited by 116 · see citing works
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
Kalyani, R. R. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2000280 · Cited by 101 · see citing works
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Lim, L.-L., Chow, E., & Chan, J. C. N. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00776-2 · Cited by 91 · see citing works
Kloecker, D., Davies, M., Khunti, K., & Zaccardi, F. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3286 · Cited by 82 · see citing works
Biguanides: Species with versatile therapeutic applications
Kathuria, D., Raul, A. D., Wanjari, P. J., & Bharatam, P. V. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113378 · Cited by 86 · see citing works
The trials and tribulations of determining HbA1c targets for diabetes mellitus
Klein, K. R., & Buse, J. B. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00425-6 · Cited by 86 · see citing works
Monocytes and macrophages as protagonists in vascular complications of diabetes
Kanter, J. E., Hsu, C.-C., & Bornfeldt, K. E. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00010 · Cited by 76 · see citing works
Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus
Chen, Y., Zhao, X., & Wu, H. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312192 · Cited by 71 · see citing works
Vijan, S. S. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201911050 · Cited by 71 · see citing works
Schernthaner, G., Brand, K. M. G., & Bailey, C. J. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155160 · Cited by 70 · see citing works
Wang, J., Huang, X., Liu, H., Chen, Y., Li, P., Liu, L., Li, J., Ren, Y., Huang, J., Xiong, E., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1122494 · Cited by 67 · see citing works
Rethinking Chronic Kidney Disease in the Aging Population
Alfano, G., Perrone, R., Fontana, F., Ligabue, G., Giovanella, S., Ferrari, A., Gregorini, M., Cappelli, G., Magistroni, R., & Donati, G. (2022) · Life · doi:10.3390/life12111724 · Cited by 64 · see citing works
Prattichizzo, F., de Candia, P., Nigris, V. D., Nicolucci, A., & Ceriello, A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154308 · Cited by 64 · see citing works
Nigussie, S., Birhan, N., Amare, F., Mengistu, G., Adem, F., & Abegaz, T. M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0251506 · Cited by 62 · see citing works
Metas no tratamento do diabetes
de Almeida-Pititto, B., Rodrigues, M. L. D., de Moura, F. F., Lamounier, R. N., Vencio, S. A. C., Calliari, L. E., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-3 · Cited by 87 · see citing works
Patoulias, D., Papadopoulos, C. E., Stavropoulos, K., Zografou, I., Doumas, M. N., & Karagiannis, A. I. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13831 · Cited by 57 · see citing works
Chen, J., Yin, D., & Dou, K. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01875-8 · Cited by 63 · see citing works
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction
Schmitt, V. H., Hobohm, L., Münzel, T. F., Wenzel, P., Gori, T., & Keller, K. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.003 · Cited by 56 · see citing works
Tao, L., Huang, X., Xu, M., Yang, L., & Hua, F. (2019) · The FASEB Journal · doi:10.1096/fj.201901838r · Cited by 53 · see citing works
Genetic-code-expanded cell-based therapy for treating diabetes in mice
Chen, C., Yu, G., Huang, Y., Cheng, W., Li, Y., Sun, Y. X., Ye, H., & Liu, T. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00899-z · Cited by 51 · see citing works
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. K. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.002 · Cited by 54 · see citing works
Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors
Dabravolski, S. A., Zhuravlev, A. D., Kartuesov, A. G., Borisov, E. E., Sukhorukov, V. N., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105371 · Cited by 48 · see citing works
Predicting 5- and 10-year mortality risk in older adults with diabetes
Griffith, K. N., Prentice, J. C., Mohr, D. C., & Conlin, P. R. (2020) · Diabetes Care · doi:10.2337/dc19-1870 · Cited by 48 · see citing works
Arroyave, F., Montaño, D., & Lizcano, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228685 · Cited by 48 · see citing works
The legacy effect in diabetes: are there long-term benefits?
Folz, R., & Laiteerapong, N. (2021) · Diabetologia · doi:10.1007/s00125-021-05539-8 · Cited by 46 · see citing works
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. K. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.05.004 · Cited by 45 · see citing works
Crawford, A. L., & Laiteerapong, N. (2024) · Annals of Internal Medicine · doi:10.7326/aitc202406180 · Cited by 47 · see citing works
Carew, A. S., Levy, A. P., Ginsberg, H. N., Coca, S. G., Lache, O., Ransom, T. P. P., Byington, R. P., Rimm, E. B., Sapp, J. L., Gardner, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.051 · Cited by 43 · see citing works
Regassa, L. D., Tola, A., & Ayele, Y. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.532719 · Cited by 41 · see citing works
Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids
Semova, I., Levenson, A. E., Krawczyk, J., Bullock, K. H., Gearing, M. E., Ling, A. V., Williams, K., Miao, J., Adamson, S. S., Shin, D., et al. (2022) · Circulation · doi:10.1161/circulationaha.120.045373 · Cited by 41 · see citing works
Li, J., He, K., Ge, J., Li, C., & Jing, Z. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108656 · Cited by 41 · see citing works
Shita, N. G., & Iyasu, A. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13673-5 · Cited by 40 · see citing works
Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms
Izundegui, D. G., & Nayor, M. G. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01449-0 · Cited by 37 · see citing works
Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm
Bar‐Tana, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09545-w · Cited by 34 · see citing works
Diabetes and stroke: An important complication
Bloomgarden, Z. T., & CHILTON, R. J. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13142 · Cited by 35 · see citing works
Tye, S. C., Jongs, N., Coca, S. G., Sundström, J., Arnott, C. G., Neal, B. C., Perkovic, V., Mahaffey, K. W., Vart, P., & Heerspink, H. J. L. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01619-0 · Cited by 34 · see citing works
Sheng, L., Yang, G., Chai, X., Zhou, Y., Sun, X., & Xing, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1323571 · Cited by 35 · see citing works
HMGB1 impairs endothelium‐dependent relaxation in diabetes through TLR4/eNOS pathway
Zhu, Z., Peng, X., Li, X., Tu, T., Yang, H., Teng, S., Zhang, W., Xing, Z., Tang, J., Hu, X., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000242r · Cited by 32 · see citing works
Webb, D. R., Davies, M. J., Jarvis, J., Seidu, S., & Khunti, K. K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107836 · Cited by 30 · see citing works
Sun, Y., Ni, W., Yuan, X., Chi, H., & Xu, J. (2020) · BMC Public Health · doi:10.1186/s12889-020-09045-1 · Cited by 30 · see citing works
Intensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus
Sasako, T., Yamauchi, T., & Ueki, K. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0325 · Cited by 30 · see citing works
Review of the veteran affairs diabetes trial: Lessons learned
Tran, K., & Reaven, P. D. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09558-5 · Cited by 27 · see citing works
Self-citationNahmias, A., Stahel, P., Xiao, C., & Lewis, G. F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00100 · Cited by 29 · see citing works
Glucagon: Its evolving role in the management of hypoglycemia
Isaacs, D. M., Clements, J. N., Turco, N., & Hartman, R. (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2534 · Cited by 28 · see citing works
The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy
Tao, L., Wang, T., Lu, Z., Hua, F., & Li, J. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.192 · Cited by 27 · see citing works
Giorgino, F., Caruso, I., Moellmann, J., & Lehrke, M. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154045 · Cited by 26 · see citing works
Hanssen, N. M. J., Scheijen, J. L. J. M., Houben, A. J. H. M., van de Waarenburg, M. P. H., Berendschot, T. T. J. M., Webers, C. A. B., Reesink, K. D., van Greevenbroek, M. M. J., Kallen, C., Schaper, N. C., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.02.002 · Cited by 26 · see citing works
Hosseini, M. M., Zargoush, M., Alemi, F., & Kheirbek, R. (2020) · Journal Of Big Data · doi:10.1186/s40537-020-00302-z · Cited by 27 · see citing works
Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus
Kim, J., & Kwon, H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0377 · Cited by 28 · see citing works
Association of Social and Behavioral Risk Factors With Mortality Among US Veterans With COVID-19
Kelly, J. D., Bravata, D. M., Bent, S., Wray, C. M., Leonard, S. J., Boscardin, W. J., Myers, L. J., & Keyhani, S. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.13031 · Cited by 25 · see citing works
Zhong, X., Wang, T., Zhang, W., Wang, M., Xie, Y., Dai, L., He, X., Madhusudhan, T., Zeng, H., & Wang, H. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101989 · Cited by 25 · see citing works
The cardiovascular complications of diabetes: a striking link through protein glycation
Ahmad, M. N., Farah, A. I., & Al‐Qirim, T. M. (2020) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2020-0021 · Cited by 24 · see citing works
Hu, X., Li, W., Wang, C., Zhang, H., Lu, H., Li, G., Zhou, Y., & Dong, H. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9238566 · Cited by 24 · see citing works
Glycaemic control in people with diabetes following acute myocardial infarction
Esdaile, H., Hill, N. E., Mayet, J., & Oliver, N. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110644 · Cited by 27 · see citing works
Rosén, H. C., Mohammad, M. A., Jernberg, T., James, S. K., Oldgren, J., & Erlinge, D. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101032 · Cited by 24 · see citing works
Derosa, G., D’Angelo, A., Martinotti, C., Valentino, M. C., Matteo, S. D., Bruno, G. M., & Maffioli, P. (2020) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000673 · Cited by 23 · see citing works
Rai, A. K., Lee, B., Gomez, R., Rajendran, D., Khan, M., & Garikipati, V. N. S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.612722 · Cited by 23 · see citing works
Genetics of Type 2 Diabetes: Opportunities for Precision Medicine
Kim, D. S., Gloyn, A. L., & Knowles, J. W. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.346 · Cited by 25 · see citing works
Targets for blood glucose: What have the trials told us
Valensi, P. E., Prévost, G., Schnell, O., Standl, E., & Ceriello, A. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319885456 · Cited by 23 · see citing works
Management of Diabetes in Patients Undergoing Bariatric Surgery
Mulla, C. M., Baloch, H. M., & Hafida, S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1242-2 · Cited by 23 · see citing works
Gunadhar, P., Goodwin, S. M., Livingston, K. A., & Karlsen, M. C. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231181574 · Cited by 21 · see citing works
Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population
Schmitt, V. H., Billaudelle, A.-M., Schulz, A., Keller, K., Hahad, O., Tröbs, S., Koeck, T., Michal, M., Schuster, A. K.-G., Toenges, G., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173851 · Cited by 21 · see citing works
Agrawal, L., Azad, N., Bahn, G. D., Reaven, P. D., Hayward, R. A., Reda, D. J., Emanuele, N. V., VADT Study Group, Abraira, C., Duckworth, W. C., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0891 · Cited by 20 · see citing works
Self-citationFunamizu, T., Iwata, H., Nishida, Y., Miyosawa, K., Doi, S., Chikata, Y., Shitara, J., Endo, H., Wada, H., Naito, R., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-00996-8 · Cited by 23 · see citing works
Nair, R. G., Vasudev, M. M., & Mavathur, R. N. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaab043 · Cited by 19 · see citing works
The Changing Landscape of Pharmacotherapy for Diabetes Mellitus: A Review of Cardiovascular Outcomes
Wu, L., & Gunton, J. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235853 · Cited by 19 · see citing works
Park, G., Lee, C. H., Lee, S., Yun, S., Kim, Y., Kim, Y., Won, K.-B., Ann, S. H., Kim, S.-J., Kang, J., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0073 · Cited by 18 · see citing works
The Legacy Effect in the Prevention of Cardiovascular Disease
Esmel, E. V., Naval-Álvarez, J., & Sacanella, E. (2020) · Nutrients · doi:10.3390/nu12113227 · Cited by 17 · see citing works
Kloecker, D. E., Khunti, K., Davies, M. J., Pitocco, D., & Zaccardi, F. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.08.047 · Cited by 16 · see citing works
Jha, M. K., Fatt, C. C., Minhajuddin, A., Mayes, T. L., Berry, J. D., & Trivedi, M. H. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105921 · Cited by 16 · see citing works
Foussard, N., Dari, L., Ducasse, É., Rigalleau, V., Mohammedi, K., & Caradu, C. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104164 · Cited by 16 · see citing works
Patoulias, D., Katsimardou, A., Kalogirou, M., Zografou, I., Toumpourleka, M., Imprialos, K. P., Stavropoulos, K., Stergiou, I., Papadopoulos, C. E., & Doumas, M. N. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.04.001 · Cited by 15 · see citing works
Kuzemczak, M., Ibrahem, A., & Alkhalil, M. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01056-z · Cited by 16 · see citing works
Guo, H., Song, B., Zhou, R., Yu, J., Chen, P., Yang, B., Pan, N., Li, C., Zhu, Y., & Wang, J. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s436816 · Cited by 14 · see citing works
Wen, M., Sun, X., Pan, L., Jing, S., Zhang, X., Liang, L., Xiao, H., Liu, P., Xu, Z., Zhang, Q., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176799 · Cited by 14 · see citing works
Sriphrapradang, C., Thewjitcharoen, Y., Buranapin, S., Sawanyawisuth, K., Yenseung, N., Ubonchareon, W., Limpijankit, L., & Himathongkam, T. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1808454 · Cited by 14 · see citing works
Hayek, A. A., & Dawish, M. A. A. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02053-0 · Cited by 14 · see citing works
Cardoso, C. R. L., Leite, N. C., & Salles, G. F. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108124 · Cited by 12 · see citing works
Choi, Y., Jacobs, D. R., Bancks, M. P., Lewis, C. E., Cha, E., Yan, F., Carnethon, M. R., Schreiner, P. J., & Duprez, D. A. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027558 · Cited by 12 · see citing works
Hata, S., Ushigome, E., Hosomi, Y., Yoshimura, T., Takegami, M., Kitagawa, N., Tanaka, T., Hasegawa, G., Ohnishi, M., Tsunoda, S., et al. (2023) · Hypertension Research · doi:10.1038/s41440-022-01136-3 · Cited by 12 · see citing works
Senior, P. A. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.001 · Cited by 12 · see citing works
- Authors
- Reaven, P. D., Emanuele, N. V., Wiitala, W. L., Bahn, G. D., Reda, D. J., McCarren, M., Duckworth, W. C., & Hayward, R. A.
- Affiliations
- VA Ann Arbor Healthcare System (US)
- Edward Hines, Jr. VA Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-06-06
- Volume
- 380
- Issue
- 23
- Pages
- 2215-2224
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6706253
- OpenAlex
- W2955148946
- Cited by
- 228
- References
- 36
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 21 · 2023: 35 · 2022: 35 · 2021: 34 · 2020: 50 · 2019: 27 · 2018: 1
- FWCI
- 29.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- VA Cooperative Studies Program (NCT00032487)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- tight glycemic control, type 2 diabetes, HbA1c, cardiovascular events, major adverse cardiovascular events, long-term follow-up, military veterans, glycemic control, cardiovascular mortality, myocardial infarction, stroke, congestive heart failure, amputation
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hyperglycemia, Hypoglycemic Agents, Male, Middle Aged, Quality of Life, Veterans, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
